The Effect of Mdr-1 Gene Polymorphism Genotypes on The Structure and Effectiveness of Treatment of Chronic Gastritis

Abstract

This article discusses the introduction of genotyping of patients with chronic gastritis by polymorphisms of the MDR-1 gene, especially by polymorphic marker C3435T of this gene, to ensure the effectiveness and safety of pharmacotherapy. The obtained results of pharmacoeconomics on the genotype of the C3435T polymorphism gene of the MDR1 gene in patients with chronic gastritis are also presented.